66.78 USD
+1.04 (+1.58%)
Last: Feb 10, 2026, 03:38 PM
LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- LIVN had positive earnings in the past year.
- In the past year LIVN had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
- Of the past 5 years LIVN 4 years had a positive operating cash flow.
1.2 Ratios
- With a decent Return On Assets value of -8.48%, LIVN is doing good in the industry, outperforming 64.52% of the companies in the same industry.
- LIVN has a Return On Equity of -18.76%. This is in the better half of the industry: LIVN outperforms 61.83% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 8.38%, LIVN belongs to the top of the industry, outperforming 86.02% of the companies in the same industry.
- LIVN had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 8.79%.
- The last Return On Invested Capital (8.38%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| ROIC | 8.38% |
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 15.01%, LIVN belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
- In the last couple of years the Operating Margin of LIVN has grown nicely.
- LIVN has a better Gross Margin (68.50%) than 75.27% of its industry peers.
- LIVN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.01% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% |
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LIVN is destroying value.
- LIVN has about the same amout of shares outstanding than it did 1 year ago.
- Compared to 5 years ago, LIVN has more shares outstanding
- Compared to 1 year ago, LIVN has a worse debt to assets ratio.
2.2 Solvency
- LIVN has an Altman-Z score of 1.81. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
- LIVN has a Altman-Z score (1.81) which is in line with its industry peers.
- LIVN has a debt to FCF ratio of 2.26. This is a good value and a sign of high solvency as LIVN would need 2.26 years to pay back of all of its debts.
- LIVN has a better Debt to FCF ratio (2.26) than 86.56% of its industry peers.
- LIVN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.30, LIVN perfoms like the industry average, outperforming 52.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.26 | ||
| Altman-Z | 1.81 |
ROIC/WACC0.97
WACC8.64%
2.3 Liquidity
- A Current Ratio of 1.32 indicates that LIVN should not have too much problems paying its short term obligations.
- LIVN's Current ratio of 1.32 is on the low side compared to the rest of the industry. LIVN is outperformed by 76.88% of its industry peers.
- LIVN has a Quick Ratio of 1.12. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
- LIVN has a Quick ratio of 1.12. This is in the lower half of the industry: LIVN underperforms 72.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 12.24% over the past year.
- The Earnings Per Share has been growing slightly by 1.82% on average over the past years.
- Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
- The Revenue has been growing slightly by 2.94% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
3.2 Future
- Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.20% on average per year.
- LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.67% yearly.
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y7.67%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 17.35, the valuation of LIVN can be described as rather expensive.
- 87.63% of the companies in the same industry are more expensive than LIVN, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 28.06. LIVN is valued slightly cheaper when compared to this.
- Based on the Price/Forward Earnings ratio of 15.84, the valuation of LIVN can be described as correct.
- LIVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 89.25% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 27.86. LIVN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.35 | ||
| Fwd PE | 15.84 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 84.95% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, LIVN is valued cheaper than 91.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.99 | ||
| EV/EBITDA | 13.68 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)9.55
EPS Next 2Y11.85%
EPS Next 3Y10.47%
5. Dividend
5.1 Amount
- LIVN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:LIVN (2/10/2026, 3:38:16 PM)
66.78
+1.04 (+1.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners105.72%
Inst Owner Change-1.34%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.65B
Revenue(TTM)1.35B
Net Income(TTM)-217.00M
Analysts82.35
Price Target73.19 (9.6%)
Short Float %3.37%
Short Ratio3.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)3.41%
PT rev (3m)12.77%
EPS NQ rev (1m)0.65%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0.12%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.35 | ||
| Fwd PE | 15.84 | ||
| P/S | 2.7 | ||
| P/FCF | 18.99 | ||
| P/OCF | 14.53 | ||
| P/B | 3.15 | ||
| P/tB | 27.63 | ||
| EV/EBITDA | 13.68 |
EPS(TTM)3.85
EY5.77%
EPS(NY)4.22
Fwd EY6.31%
FCF(TTM)3.52
FCFY5.26%
OCF(TTM)4.6
OCFY6.88%
SpS24.7
BVpS21.2
TBVpS2.42
PEG (NY)1.03
PEG (5Y)9.55
Graham Number42.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| ROCE | 11.71% | ||
| ROIC | 8.38% | ||
| ROICexc | 13.38% | ||
| ROICexgc | 250.34% | ||
| OM | 15.01% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% | ||
| FCFM | 14.23% |
ROA(3y)-0.17%
ROA(5y)-4.25%
ROE(3y)-0.33%
ROE(5y)-8.59%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.41%
ROICexc growth 3Y38.4%
ROICexc growth 5Y24.59%
OM growth 3Y41.74%
OM growth 5Y18.94%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.26 | ||
| Debt/EBITDA | 1.41 | ||
| Cap/Depr | 132.77% | ||
| Cap/Sales | 4.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.81 |
F-Score6
WACC8.64%
ROIC/WACC0.97
Cap/Depr(3y)78.92%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.86%
EPS Next 2Y11.85%
EPS Next 3Y10.47%
EPS Next 5Y13.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.67%
Revenue Next 3Y7.95%
Revenue Next 5Y7.67%
EBIT growth 1Y51.48%
EBIT growth 3Y51.06%
EBIT growth 5Y22.44%
EBIT Next Year41.25%
EBIT Next 3Y18.09%
EBIT Next 5Y3.36%
FCF growth 1Y2168.7%
FCF growth 3Y20.84%
FCF growth 5YN/A
OCF growth 1Y532.9%
OCF growth 3Y21.3%
OCF growth 5YN/A
LIVANOVA PLC / LIVN FAQ
Can you provide the ChartMill fundamental rating for LIVANOVA PLC?
ChartMill assigns a fundamental rating of 5 / 10 to LIVN.
Can you provide the valuation status for LIVANOVA PLC?
ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.
What is the profitability of LIVN stock?
LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.
What is the financial health of LIVANOVA PLC (LIVN) stock?
The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.
Can you provide the expected EPS growth for LIVN stock?
The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 16.86% in the next year.